Synthekine Showcases Updated Clinical and Translational Data Highlighting Strong STK-012 Activity in First-Line Non-Squamous NSCLC at AACR 2026 Synthekine, a clinical-stage biotechnology firm focused on engineering precision cytokine therapeutics, has…
AV Laboratories Transforms IVF Science into Breakthrough Skin Longevity Innovations AV Laboratories is positioning itself at the forefront of a new era in skincare by bringing together decades of advanced…
CareDx to Present Over 50 Abstracts, Including 16 Oral Presentations, at ISHLT 46th Annual Meeting CareDx, a leading precision medicine organization dedicated to advancing transplant care through innovative diagnostic and…
FDA Grants Approval to Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) Merck & Co. (NYSE: MRK), known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug…
Pfizer Highlights Oncology Innovation and Advances in Next-Generation Pipeline at ASCO 2026 Pfizer Inc. (NYSE: PFE) has announced an extensive and data-rich presence at the American Society of Clinical Oncology…
Genentech’s Enspryng (Satralizumab) Cuts Relapse Risk by 68%, Showing Promise as a Potential First Treatment for MOGAD Genentech, a member of the Roche Group, has announced compelling new results from…
Donor Funding Drives $15M Initiative Supporting 62 Researchers Focused on Alzheimer’s, Macular Degeneration, and Glaucoma The BrightFocus Foundation has announced a major new investment of $15.2 million in research grants…
AHF Initiates Statewide Campaign Calling for Full Reinstatement of Florida’s AIDS Drug Assistance Program The AIDS Healthcare Foundation (AHF) has launched a statewide public awareness campaign urging Ron DeSantis and…
Agenus to Showcase Initial Phase 2 Botensilimab Results in Advanced Cutaneous Melanoma at ASCO 2026 Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company focused on developing next-generation cancer immunotherapies, announced…
Real Time Medical Systems Highlights New Leadership, AI Solutions, and Expanded Partnership at NAACOS Spring 2026 Real Time Medical Systems (Real Time), a KLAS-rated and HITRUST R2 Certified leader in…
n-Lorem Foundation Reaches Key Milestone with 50th Nano-Rare Patient Treated Using a Personalized Antisense Oligonucleotide Therapy n-Lorem, a nonprofit foundation dedicated to advancing precision genetic medicine for individuals with ultra-rare…
U.S. Food and Drug Administration Accepts Filing for Genentech’s Gazyva Targeting the Most Prevalent Form of Lupus Genentech, a member of the Roche Group, has announced a major regulatory milestone…